Bambusa Therapeutics, Inc.

BBTX·NasdaqGS·Healthcare
Compare
16.07+0.07 (+0.44%)today
At close: Nov 4, 4:00 PM EST · May be delayed up to 15 min · USD

Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close16.00
Open15.96
Day range15.3116.55
52-week range13.6017.42
Off day high−2.90%
Off 52-week high−7.75%
Volume251.93K
Avg. volume (3M)790.25K
Market cap799.67M
EPS (TTM)-1.73
Forward P/E—
P/E ratio (TTM)—
Dividend yield—
Beta (5Y)—
Shares outstanding49.76M
Short interest—
Earnings date—
Analyst target—
Profit margin0.00%

Against its peers

Compare in full ›
BBTX BCAX ABCL OABI STTK ACRS
Market cap 799.67M 588.28M 3.98B 755.56M 516.87M 570.34M
P/E (TTM) — — — — — —
Forward P/E — -2.6 -16.1 -19.9 -10.0 -5.1
Price/book -1.8 1.3 4.2 3.0 2.5 4.1
Dividend yield — — — — — —
1-year change +7.20% −38.98% +171.08% +275.36% +162.76% +62.11%
Today +0.44% −0.78% +0.82% +0.58% −5.85% −1.60%

The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.

Latest news

All BBTX news ›
vir.com.vn··3 outletsPositive

Bambusa Therapeutics prices upsized initial public offering on Nasdaq

Clinical-stage biopharmaceutical firm Bambusa Therapeutics priced its upsized initial public offering on the Nasdaq Stock Market under the ticker symbol BBTX to fund antibody development. Bambusa Therapeutics prices upsized initial public…

More from 2 other outlets
@Nasdaq·Positive

Bambusa Therapeutics Rings the Opening Bell

About This EventBambusa Therapeutics (Nasdaq: BBTX), a clinical-stage biopharmaceutical company developing next-generation, long-acting precision bispecific antibodies for immunology and inflammation, visits the Nasdaq MarketSite in Times…

From the 4Search news index, newest first.

In the news

27mentions in 30 days
24with it in the headline
Positivesentiment

Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 27 articles, not a forecast.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4SEARCH.business index. Terms of use. How to use Finance